Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

Polymyalgia rheumatica is effectively treated with glucocorticoids. However, glucocorticoid treatment can cause numerous and potentially serious side effects. Therefore, lowest effective dose and shortest duration to control disease is aimed for and glucocorticoid-sparing treatments are needed. Neve...

Full description

Bibliographic Details
Main Authors: B.D. Nielsen, B. Dasgupta
Format: Article
Language:English
Published: PAGEPress Publications 2018-03-01
Series:Reumatismo
Subjects:
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/1070
_version_ 1818246677054619648
author B.D. Nielsen
B. Dasgupta
author_facet B.D. Nielsen
B. Dasgupta
author_sort B.D. Nielsen
collection DOAJ
description Polymyalgia rheumatica is effectively treated with glucocorticoids. However, glucocorticoid treatment can cause numerous and potentially serious side effects. Therefore, lowest effective dose and shortest duration to control disease is aimed for and glucocorticoid-sparing treatments are needed. Nevertheless, development of treatment regimens in PMR has been hampered by the lack of reliable classification criteria and evidence-based outcome measures. In this editorial, we discuss the need for valid classification criteria in PMR, the strengths and limitations of the ACR/EULAR 2012 provisional classification criteria for PMR and the need of validation and possible refining of the criteria.
first_indexed 2024-12-12T14:52:36Z
format Article
id doaj.art-eef8a30c16114cb69b978ddf1bcacab2
institution Directory Open Access Journal
issn 0048-7449
2240-2683
language English
last_indexed 2024-12-12T14:52:36Z
publishDate 2018-03-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj.art-eef8a30c16114cb69b978ddf1bcacab22022-12-22T00:20:58ZengPAGEPress PublicationsReumatismo0048-74492240-26832018-03-017011910.4081/reumatismo.2018.1070765Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumaticaB.D. Nielsen0B. Dasgupta1Department of Rheumatology and Department of Clinical Medicine, Aarhus University HospitalRheumatology Department, Southend University Hospital, Westcliff-on-seaPolymyalgia rheumatica is effectively treated with glucocorticoids. However, glucocorticoid treatment can cause numerous and potentially serious side effects. Therefore, lowest effective dose and shortest duration to control disease is aimed for and glucocorticoid-sparing treatments are needed. Nevertheless, development of treatment regimens in PMR has been hampered by the lack of reliable classification criteria and evidence-based outcome measures. In this editorial, we discuss the need for valid classification criteria in PMR, the strengths and limitations of the ACR/EULAR 2012 provisional classification criteria for PMR and the need of validation and possible refining of the criteria.http://www.reumatismo.org/index.php/reuma/article/view/1070Polymyalgia rheumaticaClassificationDiagnosis.
spellingShingle B.D. Nielsen
B. Dasgupta
Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
Reumatismo
Polymyalgia rheumatica
Classification
Diagnosis.
title Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
title_full Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
title_fullStr Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
title_full_unstemmed Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
title_short Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
title_sort perspectives and unmet needs in polymyalgia rheumatica providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica
topic Polymyalgia rheumatica
Classification
Diagnosis.
url http://www.reumatismo.org/index.php/reuma/article/view/1070
work_keys_str_mv AT bdnielsen perspectivesandunmetneedsinpolymyalgiarheumaticaprovidingthefundamentalframeworkforthedevelopmentofnewtreatmentregimesinpolymyalgiarheumatica
AT bdasgupta perspectivesandunmetneedsinpolymyalgiarheumaticaprovidingthefundamentalframeworkforthedevelopmentofnewtreatmentregimesinpolymyalgiarheumatica